Eli Lilly's $1 Billion Bet on Telangana: A Pharma Giant's Expansion Unveiled

US pharma giant Eli Lilly is investing $1 billion in Telangana to boost its manufacturing and global medicine supply capabilities. This move underscores Eli Lilly's belief in India's potential and Telangana's robust ecosystem. The investment includes a new plant, creating numerous job opportunities in Hyderabad.

US pharmaceutical giant Eli Lilly has announced a $1 billion investment in Telangana, aiming to strengthen its manufacturing and global medicine supply capabilities. The Indian state, renowned for its burgeoning pharma industry, will see a new manufacturing plant and quality center established in Hyderabad.

The decision was formalized after Eli Lilly's global delegation met with Telangana's Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu, highlighting the state's advantageous ecosystem of skilled manpower and infrastructure.

Emphasizing Eli Lilly's confidence in India, Executive Vice President Patrik Jonsson noted the move underscores India's strategic role in their network. As the company gears up for recruitment, new jobs will emerge in engineering, chemistry, and management, reinforcing Hyderabad's status as a pharmaceutical hub.

(With inputs from agencies.)